{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:13:21Z","timestamp":1791486801554,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.03.022","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:16:01Z","timestamp":1649178961000},"page":"2875-2883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008\u20132019"],"prefix":"10.1016","volume":"40","author":[{"given":"Iv\u00e1n Felipe","family":"Guti\u00e9rrez-Tobar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Londo\u00f1o-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mari\u00f1o-Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Beltr\u00e1n-Higuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Camacho-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura Lucia","family":"Leal-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Alberto","family":"Pati\u00f1o-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Isabel","family":"\u00c1lvarez-Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Barrero-Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Marcela","family":"Moreno-Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Rocio","family":"Sierra Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pescador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Monta\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10063","key":"10.1016\/j.vaccine.2022.03.022_b0005","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"9875","key":"10.1016\/j.vaccine.2022.03.022_b0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.022_b0015","unstructured":"The Albert B. Sabin Vaccine Institute (SVI) PAHOP, GAVI\u2019s Pneumococcal Accelerated Development and Introduction Plan at Johns Hopkins (PneumoADIP), Centers for Disease Control and Prevention (CDC). The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A review of the evidence and a preliminary economic analysis. 2007."},{"issue":"9","key":"10.1016\/j.vaccine.2022.03.022_b0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"9693","key":"10.1016\/j.vaccine.2022.03.022_b0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.022_b0030","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2022.03.022_b0035","year":"200049","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2022.03.022_b0040","unstructured":"Organization. WH. Immunization coverage 2018 2018 [Available from: http:\/\/www.who. int\/mediacentre\/factsheets\/fs378\/en\/."},{"issue":"43","key":"10.1016\/j.vaccine.2022.03.022_b0045","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","article-title":"The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis","volume":"35","author":"Alicino","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2022.03.022_b0050","doi-asserted-by":"crossref","first-page":"e0166736","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.03.022_b0055","doi-asserted-by":"crossref","unstructured":"Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S, et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis. 2014;58(7):918-24.","DOI":"10.1093\/cid\/ciu006"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":"Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.022_b0065","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3201\/eid1710.101825","article-title":"Bacterial causes of empyema in children, Australia, 2007\u20132009","volume":"17","author":"Strachan","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"50","key":"10.1016\/j.vaccine.2022.03.022_b0070","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0075","doi-asserted-by":"crossref","first-page":"e0172690","DOI":"10.1371\/journal.pone.0172690","article-title":"Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study","volume":"12","author":"Palmu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.03.022_b0080","unstructured":"Direcci\u00f3n de Redes en Salud P\u00fablica. Subdirecci\u00f3n Laboratorio Nacional de Referencia, Grupo de Microbiolog\u00eda. Instituto Nacional de Salud de Colombia. Vigilancia por Laboratorio de aislamientos invasores de Streptococcus pneumoniae Colombia 2006\u20132017 [Internet]. 2018. 1\u2013[accessed 2018 May 8]. www.ins.gov.co\/buscador-even-tos\/Informacin de laboratorio\/Vigilancia por Laboratorio de S pneumoniae 2006-2017.pdf."},{"issue":"36","key":"10.1016\/j.vaccine.2022.03.022_b0085","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1016\/j.vaccine.2017.05.059","article-title":"Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies","volume":"36","author":"Ben-Shimol","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/INF.0b013e31823dcc72","article-title":"The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance","volume":"31","author":"Ampofo","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.022_b0095","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2019.12.038","article-title":"Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine","volume":"38","author":"Berezin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.022_b0100","doi-asserted-by":"crossref","unstructured":"Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, et al. Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017. Pediatrics. 2019;144(3).","DOI":"10.1542\/peds.2019-0567"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2471\/BLT.12.109231","article-title":"Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine","volume":"91","author":"Strachan","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.vaccine.2022.03.022_b0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00431-010-1195-6","article-title":"Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7)","volume":"169","author":"Chibuk","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2022.03.022_b0115","doi-asserted-by":"crossref","unstructured":"Olarte L, Barson WJ, Barson RM, Romero JR, Bradley JS, Tan TQ, et al. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017;64(12):1699-704.","DOI":"10.1093\/cid\/cix115"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.022_b0120","first-page":"749","article-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine","volume":"48","author":"Syrogiannopoulos","year":"2016","journal-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0125","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children \u2013 A Population-Based Study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.022_b0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"The Lancet Respiratory Medicine"},{"issue":"13","key":"10.1016\/j.vaccine.2022.03.022_b0135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2013.11.028","article-title":"Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec","volume":"32","author":"De Wals","year":"2014","journal-title":"Canada Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.022_b0140","doi-asserted-by":"crossref","unstructured":"Leal AL, Monta\u00f1ez AM, Buitrago G, Pati\u00f1o J, Camacho G, Moreno VM. Impact of Ten-Valent Pneumococcal Conjugate Vaccine Introduction on Serotype Distribution Trends in Colombia: An Interrupted Time-Series Analysis. Open Forum Infect Dis2017. p. S463..","DOI":"10.1093\/ofid\/ofx163.1182"},{"issue":"9","key":"10.1016\/j.vaccine.2022.03.022_b0145","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1080\/21645515.2019.1710411","article-title":"Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogot\u00e1, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10","volume":"16","author":"Camacho Moreno","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4067\/S0716-10182016000300009","article-title":"Statement of the Advisory Immunization Committee of the Chilean Society of Infectious Diseases on the emergence of serotype 19A pneumococcal infection and the use of pneumococcal conjugated vaccine in Chilean children","volume":"33","author":"Potin","year":"2016","journal-title":"Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia"},{"issue":"36","key":"10.1016\/j.vaccine.2022.03.022_b0155","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2019.07.043","article-title":"Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil","volume":"37","author":"Brandileone","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.022_b0160","article-title":"Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre","volume":"147","author":"Mott","year":"2019","journal-title":"Brazil Epidemiology and infection"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.022_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/infdis\/jir755","article-title":"Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines","volume":"205","author":"Hampton","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.022_b0170","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/14760584.2019.1676155","article-title":"The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review","volume":"18","author":"Tin Tin Htar","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.03.022_b0175","doi-asserted-by":"crossref","unstructured":"Janoir C, Lepoutre A, Gutmann L, Varon E. Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France. Open Forum Infect Dis. 2016;3(1):ofw020.","DOI":"10.1093\/ofid\/ofw020"},{"key":"10.1016\/j.vaccine.2022.03.022_b0180","doi-asserted-by":"crossref","unstructured":"Wouters I, Desmet S, Van Heirstraeten L, Herzog SA, Beutels P, Verhaegen J, et al. How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(5).","DOI":"10.2807\/1560-7917.ES.2020.25.5.1900303"},{"key":"10.1016\/j.vaccine.2022.03.022_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jgar.2018.05.012","article-title":"Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria","volume":"15","author":"Setchanova","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.vaccine.2022.03.022_b0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-4-21","article-title":"Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited","volume":"4","author":"Martens","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.022_b0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jmii.2012.08.011","article-title":"Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease","volume":"47","author":"Lai","year":"2014","journal-title":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.022_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anpedi.2020.03.013","article-title":"Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units","volume":"94","author":"D\u00edaz-Conradi","year":"2021","journal-title":"An Pediatr (Barc)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:12:14Z","timestamp":1759403534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22002997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":40,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22002997"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008\u20132019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}